22Apr 2021
Geographic atrophy: where we are now and where we are going

Geographic atrophy: where we are now and where we are going

Age-related macular degeneration (AMD) affects a significant percentage of the elderly population and end-stage disease classified by either geographic atrophy (GA) or neovascular AMD (nvAMD) is one of the leading causes of vision loss worldwide. Despite the fact that there are currently treatments for nvAMD, there are no treatments in practice to prevent disease onset or progression of GA. This topic is at the forefront of ophthalmic research...

  • #ophthalmology

Like

Save

Share